Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Neckers

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Psychiatry Research|October 1, 1979
Some kinetic parameters of platelet monoamine oxidase in chronic schizophreniaR D Kobes, S G Potkin, C D Wise, et al.
Cancer Research|March 14, 2001
Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcriptionP Bonvini, W G An, A Rosolen, et al.
Blood|September 9, 2000
Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complexY Shiotsu, L M Neckers, I Wortman, et al.
The Journal of Experimental Medicine|October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsE A Grimm, R J Robb, J A Roth, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Characterization of oligonucleotide transport into living cellsS L Loke, C A Stein, X H Zhang, et al.
Leukemia|October 6, 2001
The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapyM V Blagosklonny, T Fojo, K N Bhalla, et al.
Molecular and Cellular Biology|July 1, 1987
Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cellsJ B Trepel, O R Colamonici, K Kelly, et al.
Nucleic Acids Research|June 12, 1989
Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotidesC Cazenave, C A Stein, N Loreau, et al.
Cancer Research|June 26, 1999
KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling moleculesS Soga, L M Neckers, T W Schulte, et al.
Molecular and Cellular Biology|October 1, 1996
Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathwayT W Schulte, M V Blagosklonny, L Romanova, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Psychiatry Research|October 1, 1979
Some kinetic parameters of platelet monoamine oxidase in chronic schizophreniaR D Kobes, S G Potkin, C D Wise, et al.
Cancer Research|March 14, 2001
Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcriptionP Bonvini, W G An, A Rosolen, et al.
Blood|September 9, 2000
Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complexY Shiotsu, L M Neckers, I Wortman, et al.
The Journal of Experimental Medicine|October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsE A Grimm, R J Robb, J A Roth, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Characterization of oligonucleotide transport into living cellsS L Loke, C A Stein, X H Zhang, et al.
Leukemia|October 6, 2001
The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapyM V Blagosklonny, T Fojo, K N Bhalla, et al.
Molecular and Cellular Biology|July 1, 1987
Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cellsJ B Trepel, O R Colamonici, K Kelly, et al.
Nucleic Acids Research|June 12, 1989
Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotidesC Cazenave, C A Stein, N Loreau, et al.
Cancer Research|June 26, 1999
KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling moleculesS Soga, L M Neckers, T W Schulte, et al.
Molecular and Cellular Biology|October 1, 1996
Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathwayT W Schulte, M V Blagosklonny, L Romanova, et al.
Pageof 10